Search

Your search keyword '"Escobar, Miguel A."' showing total 718 results

Search Constraints

Start Over You searched for: Author "Escobar, Miguel A." Remove constraint Author: "Escobar, Miguel A."
718 results on '"Escobar, Miguel A."'

Search Results

2. Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities to transform the care of people with hemophilia

6. Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial

7. Dynamic Imaging of Blood Coagulation Within the Hematoma of Patients With Acute Hemorrhagic Stroke

10. Foreign-Flagged Vessels Beware

12. Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study

19. An Investigation of the Mechanical Property Behaviour of Copper/AA7075 Nanocomposites Based on Machine Learning.

21. Identification and characterization of novel mutations implicated in congenital fibrinogen disorders

22. Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trial

25. Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE)

26. Retrospective chart review of GI bleeding in people with von Willebrand disease.

27. Quantitative HLA‐class‐II/factor VIII (FVIII) peptidomic variation in dendritic cells correlates with the immunogenic potential of therapeutic FVIII proteins in hemophilia A

29. Review of Historical and Zooarchaeological Data to Trace Past Biogeographic Distribution of Endangered Huemul (Hippocamelus bisulcus) to Enhance Conservation Strategies

32. A Scan of Pleiotropic Immune Mediated Disease Genes Identifies Novel Determinants of Baseline FVIII Inhibitor Status in Hemophilia-A

36. Plasma‐derived human factor X concentrate for the treatment of patients with hereditary factor X deficiency.

37. Contributors

39. Switching from Sucrose-Formulated rFVIII to Octocog Alfa (BAY 81-8973) Prophylaxis Improves Bleed Outcomes in the LEOPOLD Clinical Trials

47. Prophylaxis with recombinant von Willebrand factor ( rVWF ) in patients with type 3 von Willebrand disease ( VWD ): results of a post hoc analysis from a phase 3 trial

48. Gene Therapy with Etranacogene Dezaparvovec for Hemophilia B

50. Weaning from mechanical ventilation in intensive care units across 50 countries (WEAN SAFE): a multicentre, prospective, observational cohort study

Catalog

Books, media, physical & digital resources